SBFM · Sunshine Biopharma Inc. · Insider Trading

$0.40

Market Cap

$3.27M

3.88M

Volume · Oct 5 2.13M Avg daily vol (3M) 520.85K

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Query insider transactions through the insider trading API or MCP →

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-08-07	NATAN DAVID	Director	Award↑ Filing footnotes — Common Stock (Direct) Represents a stock award to the reporting person.	Common Stock	58,300	—	—	68,300
2026-04-14	NATAN DAVID	Director	Award↑ Filing footnotes — Common Stock (Direct) Represents a stock award to the reporting person.	Common Stock	100,000	—	—	10,000
2024-03-04	Slilaty Steve N.	Director, Chief Executive Officer, 10% Owner	Buy↑	Series B Preferred Stock	100,000	$0.10	$10,000	6
2024-02-08	Slilaty Steve N.	Director, Chief Executive Officer, 10% Owner	Buy↑	Series B Preferred Stock	20,000	$0.10	$2,000	2
2022-11-30	Sebaaly Camille	CFO/Secretary	Buy↑	Common Stock	30,000	$0.76	$22,905	9
2022-06-03	Sebaaly Camille	CFO/Secretary	Buy↑	Common Stock	25,000	$1.22	$30,500	7
2022-02-18	Slilaty Steve N.	Director, Chief Executive Officer, 10% Owner	Other↓ Filing footnotes — Series B Preferred Stock (Direct) Dr. Slilaty returned 990,000 shares of Series B Preferred Stock to the Issuer for a redemption price equal to the stated value of $0.10 per share.	Series B Preferred Stock	990,000	$0.10	$99,000	0
2021-01-06	MERZOUKI ABDERRAZZAK	Director, Chief Operating Officer	Award↑	Common Stock	20,000,000	$0.00	$20,000	1,167
2021-01-06	Slilaty Steve N.	Director, Chief Executive Officer, 10% Owner	Award↑	Common Stock	20,000,000	$0.00	$20,000	1,167
2021-01-06	Sebaaly Camille	CFO/Secretary	Award↑	Common Stock	20,000,000	$0.00	$20,000	1,195
2020-06-17	Slilaty Steve N.	Director, Chief Executive Officer, 10% Owner	Award↑	Series "B" Preferred Stock	500,000	$0.10	$50,000	50

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–11 of 11 transactions

Key facts CIK 1402328 CUSIP 867781809 Visit website Investor relations